UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.06 +0.06 (+0.08%) GOLD FUTURES
2,313.40 +2.40 (+0.10%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
46,968.75 +1,203.38 (+2.63%)
Roche Holding AG (RHHBY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 29.75 |
| Open | 29.71 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 29.20 - 29.73 |
| 52-week range | 29.20 - 40.48 |
| Volume | |
| Avg. volume | 2,745,977 |
| Market cap | 190.395B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 14.93 |
| EPS (TTM) | 1.96 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 1.35 (4.54%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | 37.86 |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
© 2024 Yahoo. All rights reserved.